Anika To Participate in December 2024 Investor Conferences

Core Viewpoint - Anika Therapeutics, Inc. is actively engaging with investors through participation in multiple upcoming conferences, showcasing its commitment to transparency and investor relations [1][2][3][4]. Group 1: Upcoming Conferences - Anika Therapeutics will present at the 36th Annual Piper Sandler Healthcare Conference in New York on December 3rd, with Dr. Cheryl Blanchard and Steve Griffin scheduled to present at 10:30am ET [2]. - The company will also participate in the Sidoti Small-Cap Virtual Conference on December 5th, where Steve Griffin is set to present at 10:45am ET [3]. - On December 11th, Anika will take part in The Benchmark Company 13th Annual Discovery One-on-One Investor Conference in New York, with both Dr. Cheryl Blanchard and Steve Griffin involved in one-on-one investor meetings [4]. Group 2: Company Overview - Anika Therapeutics is a global joint preservation company focused on early intervention orthopedic care, leveraging expertise in hyaluronic acid and implant solutions [5]. - The company aims to provide minimally invasive products for Osteoarthritis Pain Management and Regenerative Solutions, targeting high opportunity spaces within orthopedics [5]. - Anika's global operations are headquartered outside of Boston, Massachusetts, emphasizing its strategic location for healthcare innovation [5].